Browsing: Patients

Emirates Health Services (EHS) has announced the availability of BYANNLI, developed by Johnson & Johnson, for patients with schizophrenia at Al Amal Psychiatric Hospital, one of its affiliated facilities. Al… The post Emirates Health Services Announces Availability of Innovative Long-Acting Treatment for Schizophrenia appeared first on Web-Release.

Sanofi today announced that UAE health authorities have approved expanded indications for an immunomodulatory therapy in Type 1 diabetes, marking a significant milestone in the evolution of care for one… The post Sanofi Announces Expanded Proactive Care for a Disease Modifying Therapy in Type 1 Diabetes appeared first on Web-Release.

Aster DM Quality Care Limited today commenced operations following the successful completion of the merger between Aster DM Healthcare and Quality Care India Limited (QCIL), bringing together four trusted healthcare… The post Aster Quality Care begins operations with a mission to expand advanced healthcare beyond India’s metros appeared first on Web-Release.

Medcare Hospitals and Medical Centres, a leading premium healthcare provider in the UAE and part of Aster DM Healthcare Group, today announced a strategic partnership with InterSystems to implement InterSystems… The post Medcare – First Healthcare Provider in EMEA to Adopt InterSystems IntelliCare, a Next-Generation native AI-First Electronic Health Record Platform appeared first on Web-Release.

Marking 25 years of diagnostic service in the UAE, Thumbay Labs, the largest network of academic diagnostic referral laboratories in the Northern Emirates, has earned ISO 15189:2022 accreditation, the international… The post Thumbay Labs Marks 25 Years in the UAE as the largest network of Academic Labs. appeared first on Web-Release.

Medcare Royal Speciality Hospital (MRSH) in Dubai has become the world’s first hospital outside the USA to offer a newly licensed intrathecal gene therapy to any adult patients with Spinal… The post Dubai’s Medcare Hospital becomes world’s first to treat adult Spinal Muscular Atrophy (SMA) patient outside the US appeared first on Web-Release.

The Thumbay Institute of Aesthetics (TIA) at Thumbay Hospital Fujairah has successfully performed an advanced body contouring surgery on a young female patient following significant weight loss after bariatric treatment. Massive weight reduction is life-changing. But for many patients, the journey doesn’t end with the weight loss itself. Loose skin, altered body proportions, and loss […] The post Thumbay Institute of Aesthetics, Fujairah Performs Advanced Post-Bariatric Body Contouring Surgery appeared first on Web-Release.

The Thumbay Institute of Aesthetics (TIA) at Thumbay Hospital Fujairah has successfully performed an advanced body contouring surgery on a young female patient following significant weight loss after bariatric treatment. Massive weight reduction is life-changing. But for many patients, the journey doesn’t end with the weight loss itself. Loose skin, altered body proportions, and loss […] The post Thumbay Institute of Aesthetics, Fujairah Performs Advanced Post-Bariatric Body Contouring Surgery appeared first on Web-Release.

On the occasion of World Cancer Day, the LAU Medical Center – Rizk Hospital organized a heartfelt event on February 4, bringing together patients, survivors, caregivers, medical professionals, and artists in a powerful celebration of resilience, compassion, and collective healing. The event opened with a welcome address by Dr. Hady Ghanem, who emphasized the medical […] The post LAU Medical Center – Rizk Hospital Honors World Cancer Day Through Stories of Courage, Care, and Hope appeared first on Web-Release.

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.